Guggenheim Capital’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-9,343
| Closed | -$212K | – | 1996 |
|
|
2022
Q4 | $212K | Buy |
+9,343
| New | +$212K | ﹤0.01% | 1786 |
|
|
2021
Q3 | – | Sell |
-5,419
| Closed | -$211K | – | 2213 |
|
|
2021
Q2 | $211K | Sell |
5,419
-547
| -9% | -$21.3K | ﹤0.01% | 2122 |
|
|
2021
Q1 | $204K | Sell |
5,966
-5,610
| -48% | -$192K | ﹤0.01% | 2085 |
|
|
2020
Q4 | $525K | Buy |
+11,576
| New | +$525K | ﹤0.01% | 1614 |
|
|
2019
Q4 | – | Sell |
-43,125
| Closed | -$1.54M | – | 2149 |
|
|
2019
Q3 | $1.54M | Buy |
43,125
+1,680
| +4% | +$59.8K | 0.01% | 1117 |
|
|
2019
Q2 | $2.13M | Sell |
41,445
-3,150
| -7% | -$162K | 0.02% | 1032 |
|
|
2019
Q1 | $2.56M | Buy |
44,595
+2,139
| +5% | +$123K | 0.02% | 965 |
|
|
2018
Q4 | $1.78M | Buy |
+42,456
| New | +$1.78M | 0.02% | 1100 |
|